Identifying simultaneous inhibition of riboflavin metabolism and MEK as a novel therapeutic strategy for pancreatic cancer
Takako Ooshio(Hokkaido University), Masahiro Sonoshita(Hokkaido University)
Cited by 1
Related Papers
A whole-animal platform to advance a clinical kinase inhibitor into new disease space
|Nature Chemical Biology|2018|73
Integrated computational and Drosophila cancer model platform captures previously unappreciated chemicals perturbing a kinase network
|PLoS Computational Biology|2019|13
Integrated computational and <i>Drosophila</i> cancer model platform captures previously unappreciated chemicals perturbing a kinase network
|bioRxiv (Cold Spring Harbor Laboratory)|2018|1